Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Antimicrobial Hydrogel Dressings pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are hydrogel dressings impregnated with an agent that inhibits microbial growth. One unit refers to one hydrogel dressing.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Antimicrobial Hydrogel Dressings under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Antimicrobial Hydrogel Dressings and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Antimicrobial Hydrogel Dressings under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Antimicrobial Hydrogel Dressings Overview
4 Products under Development
4.1 Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
4.2 Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
4.3 Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
4.4 Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
4.5 Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
5 Antimicrobial Hydrogel Dressings - Pipeline Products under Development by Companies
5.1 Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
5.2 Antimicrobial Hydrogel Dressings – Companies Pipeline Products by Stage of Development
6 Antimicrobial Hydrogel Dressings Companies and Product Overview
6.1 CelaCare Technologies LLC Company Overview
6.1.1 CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.2 Edixomed Ltd Company Overview
6.2.1 Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.3 Gel4Med Inc Company Overview
6.3.1 Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 In2cure AB Company Overview
6.4.1 In2cure AB Pipeline Products & Ongoing Clinical Trials Overview
6.5 Institute of Nano Science and Technology Company Overview
6.5.1 Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
6.6 Novyx Technologies LLC Company Overview
6.6.1 Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.7 O2 Regentech LLC Company Overview
6.7.1 O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview
6.8 Plurogen Therapeutics Inc (Inactive) Company Overview
6.8.1 Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.9 Quick-Med Technologies Inc Company Overview
6.9.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.10 Smith & Nephew Plc Company Overview
6.10.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
6.11 Syracuse University Company Overview
6.11.1 Syracuse University Pipeline Products & Ongoing Clinical Trials Overview
7 Antimicrobial Hydrogel Dressings- Recent Developments
7.1 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update
7.2 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report
7.3 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders
7.4 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022
7.5 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting
7.6 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results
7.7 Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
7.8 Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting
7.9 Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results
7.10 Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change
7.11 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
Table 2: Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
Table 3: Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
Table 4: Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
Table 5: Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
Table 6: Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
Table 7: Antimicrobial Hydrogel Dressings – Companies Pipeline Products by Stage of Development
Table 8: CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: OTC Antimicrobial Gel - Product Status
Table 10: OTC Antimicrobial Gel - Product Description
Table 11: Prescription Gel 1 - Product Status
Table 12: Prescription Gel 1 - Product Description
Table 13: Prescription Gel 2 - Product Status
Table 14: Prescription Gel 2 - Product Description
Table 15: Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: EDX110 - Burns - Product Status
Table 17: EDX110 - Burns - Product Description
Table 18: EDX110 - Cystic Fibrosis - Product Status
Table 19: EDX110 - Cystic Fibrosis - Product Description
Table 20: EDX110 - Diabetic Foot Ulcer - Product Status
Table 21: EDX110 - Diabetic Foot Ulcer - Product Description
Table 22: EDX110 - Pressure Ulcers - Product Status
Table 23: EDX110 - Pressure Ulcers - Product Description
Table 24: EDX110 - Septic Shock - Product Status
Table 25: EDX110 - Septic Shock - Product Description
Table 26: EDX110 - Surgical Wounds - Product Status
Table 27: EDX110 - Surgical Wounds - Product Description
Table 28: EDX110 - Venous Leg Ulcers - Product Status
Table 29: EDX110 - Venous Leg Ulcers - Product Description
Table 30: Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: G4db - Product Status
Table 32: G4db - Product Description
Table 33: G4I - Product Status
Table 34: G4I - Product Description
Table 35: In2cure AB Pipeline Products & Ongoing Clinical Trials Overview
Table 36: TCP-25 - Product Status
Table 37: TCP-25 - Product Description
Table 38: In2cure AB - Ongoing Clinical Trials Overview
Table 39: TCP-25 - A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male and Female Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds
Table 40: Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Smart Injectable Hydrogel - Product Status
Table 42: Smart Injectable Hydrogel - Product Description
Table 43: Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Hydrogel Wound Dressing - Product Status
Table 45: Hydrogel Wound Dressing - Product Description
Table 46: O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 47: OXAID - Product Status
Table 48: OXAID - Product Description
Table 49: Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 50: PluroGel PNN - Product Status
Table 51: PluroGel PNN - Product Description
Table 52: Plurogen Therapeutics Inc (Inactive) - Ongoing Clinical Trials Overview
Table 53: PluroGel PNN - A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
Table 54: PluroGel PNN - A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
Table 55: Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Nimbus Hydrogel - Product Status
Table 57: Nimbus Hydrogel - Product Description
Table 58: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Wound Dressing - Product Status
Table 60: Wound Dressing - Product Description
Table 61: Syracuse University Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Antimicrobial Hydrogel Web - Product Status
Table 63: Antimicrobial Hydrogel Web - Product Description
Table 64: Shape Memory Polymer Hydrogel - Product Status
Table 65: Shape Memory Polymer Hydrogel - Product Description
Table 66: Glossary
2.2 List of Figures
Figure 1: Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
Figure 2: Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
Figure 3: Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
Figure 4: Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
Figure 5: Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings